Use of 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity

Details for Australian Patent Application No. 2004268388 (hide)

Owner Solvay Pharmaceuticals GmbH

Inventors Lange, Josephus Hubertus Maria; Antel, Jochen; Krause, Gunter; Kruse, Cornelis Gerrit; Gregory, Peter-Colin; Den Besten, Cathaline

Agent Watermark

Pub. Number AU-A-2004268388

PCT Pub. Number WO2005/020988

Priority 03019939.2 02.09.03 EP

Filing date 31 August 2004

Wipo publication date 10 March 2005

International Classifications

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/4155 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4439 (2006.01)

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

23 March 2006 PCT application entered the National Phase

  PCT publication WO2005/020988 Priority application(s): WO2005/020988

24 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004268390-Combinations of a pyrimidine containing NNRTI with RT inhibitors

2004268387-Composition comprising a pulmonary surfactant and a PDE2 inhibitor